Point72 Hong Kong’s Definium Therapeutics DFTX Stock Holding History

Point72 Hong Kong’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,121	Closed	-$58K	–	2276
2021 Q2	$58K	Buy	+1,121	New	+$58.8K	﹤0.01%	1439

Other funds holding DFTX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return

Point72 Hong Kong's DFTX Position: Q3 2021 in Review

Point72 Hong Kong sold out of Definium Therapeutics (DFTX) in Q3 2021, closing a stake of 1,121 shares — an estimated $58K sold.

Point72 Hong Kong first reported a position in DFTX in Q2 2021 and held it in 1 quarter. The position peaked at $58K in Q2 2021. 174 funds tracked by Wall St. Rank hold DFTX as of Q3 2021.

Point72 Hong Kong reported no remaining Definium Therapeutics position as of Q3 2021 after selling out during the quarter.
Point72 Hong Kong sold 1,121 Definium Therapeutics shares in Q3 2021, an estimated $58K.
Point72 Hong Kong first reported a position in Definium Therapeutics in Q2 2021 and held it in 1 quarter.
Point72 Hong Kong's Definium Therapeutics position peaked at $58K in Q2 2021.
174 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2021.

Based on Point72 Hong Kong's 13F filing for Q3 2021, filed 15 Nov 2021.